Pre-existing cardiac disease, troponin I elevation and mortality in patients with severe sepsis and septic shock

Anaesthesia and Intensive Care

Volumn 36, Issue 1, 2008, Pages 51-59

  Scott, E C ^a   Ho, H C ^a   Yu, M ^a   Chapital, A D ^a   Koss, W ^a   Takanishi Jr , D M ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Cardiac disease; Mortality; Myocardial dysfunction; Pulmonary artery catheter; Sepsis; Septic shock; Troponin I

Indexed keywords

HYPERTENSIVE FACTOR; INOTROPIC AGENT; TROPONIN I;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY CATHETERIZATION; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; SEPSIS; SEPTIC SHOCK; TACHYCARDIA;

EID: 38949107614     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0803600109     Document Type: Article

References (37)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310.
2. Krishnagopalan S, Kumar A, Parrillo JE, Kumar A. Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002; 8:376-388.
3. Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KS, Banerjee A, Harken AH. Tumor necrosis factor-alpha and interleukin-1 beta synergistically depree human myocardial function. Crit Care Med 1999; 27:1309-1318.
4. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis factor-alpha and interleukin-1 beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996; 183:949-958.
5. Cunnion RE, Schaer GL, Parker MM, Natanson C, Parrillo JE. The coronary circulation in human septic shock. Circulation 1986; 73:637-644.
6. Dhainaut JF, Huyghebaert MF, Monsallier JF, Lefevre G, Dall'Ava-Santucci J, Brunet F et al. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 1987; 75:533-541.
7. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2000; 102:1193-1209.
8. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36:959-969.
9. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335:1342-1349.
10. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA. The prognostic value of troponin in patients with non-ST-elevation acute coronary syndromes: A meta-analysis. J Am Coll Cardiol 2001; 38:478-485.
11. Relos RP, Hasinoff IK, Beilman GJ. Moderately elevated serum troponin concentrations are associated with increased morbidity and mortality rates in surgical intensive care unit patients. Crit Care Med 2003; 31:2598-2603.
12. Arlati S, Brenna S, Prencipe L, Marocchi A, Casella GP, Lanzani M et al. Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study. Intensive Care Med 2000; 26:31-37.
13. ver Elst KM, Spapen HD, Nguyen DN, Garbar C, Huyghens LP, Gorus FK. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2000; 46:650-657.
14. Ammann P, Fehr T, Minder EI, Gunter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001; 27:965-969.
15. Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003; 41:2004-2009.
16. Spies C, Haude V, Fitzner R, Schröder K, Overbeck M, Runkel N et al. Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 1998; 113:1055-1063.
17. Turner A, Tsamitros M, Bellomo R. Myocardial cell injury in septic shock. Crit Care Med 1999; 27:1775-1780.
18. Mehta NJ, Khan IA, Gupta V, Jani K, Gowda RM, Smith PR. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 2004; 95:13-17.
19. Maeder M, Fehr T, Rickli H, Ammann P. Sepsis-associated myocardial dysfunction. Diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006; 129:1349-1366.
20. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655.
21. Yu M, Burchell S, Hasaniya NW, Takanishi DM, Myers SA, Takiguchi SA. Relationship of mortality to increasing oxygen delivery in patients > 50 years of age: a prospective randomized study. Crit Care Med 1998; 26:1011-1019.
22. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B et al. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377.
23. Horwich TB, Patel J, MacLellan WR, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003; 108:833-838.
24. Apple FS, Murakami MM, Quist HH, Pearce LA, Wieczorek S, Wu AH. Prognostic value of the ortho vitros cardiac troponin I assay in patients with symptoms of myocardial ischemia. Am J Clin Pathol 2003; 120:114-120.
25. Crouser ED, Julian MW, Blaho DV, Pfeiffer DR. Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit Care Med 2002; 30:276-284.
26. Neumayr G, Pfister R, Mitterbauer G, Maurer A, Gaenzer H, Sturm W et al. Effect of the "Race Across The Alps" in elite cyclists on plasma cardiac troponins I and T. Am J Cardiol 2002; 89:484-486.
27. Rifai N, Douglas PS, O'Toole M, Rimm E, Ginsburg GS. Cardiac troponin T and I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the hawaii ironman triathlon. Am J Cardiol 1999; 83:1085-1089.
28. Neumayr G, Gaenzer H, Pfister R, Sturm W, Schwarzacher SP, Eibl G et al. Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise. Am J Cardiol 2001; 87:369-371.
29. Deibert E, Barzilai B, Braverman AC, Edwards DF, Aiyagari V, Dacey R et al. Clinical significance of elevated troponin I levels in patients with nontraumatic subarachnoid hemorrhage. J Neurosurg 2003; 98:741-746.
30. Parekh N, Venkatesh B, Cross D, Leditschke A, Atherton J, Miles W et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol 2000; 36:1328-1335.
31. Wayand D, Baum H, Schätzle G, Schärf J, Neumeier D. Cardiac troponin T and I in end-stage renal failure. Clin Chem 2000;46:1345-1350.
32. Freda BJ, Tang WH, Van Lente F, Peacock WF, Francis GS. Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol 2002; 40:2065-2071.
33. Giannitsis E, Muller-Bardorff M, Kurowski V, Weidtmann B, Wiegand U, Kampmann M et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102:211-217.
34. Konstantinides S, Geibel A, Olschewski M, Kasper W, Hruska N, Jackie S et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106:1263-1268.
35. Raper RF, Sibbald WJ. The effects of coronary artery disease on cardiac function in nonhypotensive sepsis. Chest 1988; 94:507-511.
36. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. JAMA 1995; 274:968-974.
37. Richard C, Warszawski J, Anguel N, Deye N, Combes A, Barnoud D et al. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2003; 290:2713-2720.